The overdose reversal drug could be available for purchase without a prescription as soon as the late summer.
The U.S. Food and Drug Administration announced Wednesday that it has approved over-the-counter sales of Narcan, making the overdose-reversal drug much more accessible to the public. The spray could be available without a prescription as soon as late summer.
In a statement, FDA commissioner Robert Califf said the agency is “committed” to addressing the nation’s opioid crisis, citing the “dire public-health need” as reason for approving the drug.
